Citation Impact

Citing Papers

Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Clinical Significance of a First Positive Nontuberculous Mycobacteria Culture in Cystic Fibrosis
2014
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations
2012
Multilocus sequence typing scheme for the Mycobacterium abscessus complex
2014
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Dental units: an environmental study of sources of potentially pathogenic mycobacteria
1995
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
2010
Cystic fibrosis
2016 Standout
Inhaled therapies, azithromycin andMycobacterium abscessusin cystic fibrosis patients
2012
Pulmonary Disease Due to Nontuberculous Mycobacteria
2008
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
2012
Mycobacterium simiae Outbreak Associated With a Hospital Water Supply
2004
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection
2010
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
A Review of the Research Literature on Evidence-Based Healthcare Design
2008 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Antibiotics versus biofilm: an emerging battleground in microbial communities
2019 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin
2011
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Clinical and radiological features of Mycobacterium kansasii and other NTM infections
2012
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin
2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
2013
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF)
2016
Non‐tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors
2009
Nontuberculous mycobacteria
2013
A Hospital‐Based Prevalence Survey of Bloodstream Infections in Febrile Patients in Malawi: Implications for Diagnosis and Therapy
2000
rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov.
2006 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Cystic fibrosis
2009
The Growing Burden of Tuberculosis
2003 Standout
Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London
2012
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
1990 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis
2013
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Drug Susceptibility Testing of Nontuberculous Mycobacteria
2014
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
1993 Standout
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
Guidelines for Infection Control in Dental Health Care Settings
2013 Standout
Novel Diagnostic Algorithm for Identification of Mycobacteria Using Genus-Specific Amplification of the 16S-23S rRNA Gene Spacer and Restriction Endonucleases
2000 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
A review of the main bacterial fish diseases in mariculture systems
2005 Standout
Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France
2009
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
2016
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Epidemiology of infection by nontuberculous mycobacteria
1996
The Peptidoglycan of Mycobacterium abscessus Is Predominantly Cross-Linked by l , d -Transpeptidases
2010
The global burden of typhoid fever.
2004 Standout
Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
2014
General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection
2015
Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains
2010
Clinical Characteristics and Treatment Outcomes ofMycobacterium kansasiiLung Disease in Korea
2010
Detection of Rapidly Growing Mycobacteria in Routine Cultures of Samples from Patients with Cystic Fibrosis
2011
Agents of newly recognized or infrequently encountered mycobacterial diseases
1992

Works of A. Lavy being referenced

An Outbreak ofMycobacterium jacuzziiInfection following Insertion of Breast Implants
2006
Pulmonary Mycobacterium kansasii Infection in Israel, 1999–2004
2006
Mycobacterium simiae Infection in Israeli Patients with AIDS
1993
Mycobacterium avium-intracellulare in clinical specimens: etiological factor or contaminant?
1990
Isolation of mycobacterium simiaefrom clinical specimens in israel
1982
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
2008
Rankless by CCL
2026